Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

New 5mg tablet offers the same established efficacy and safety as the Evrysdi oral solution for individuals living with spinal muscular atrophy.

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Cosmos Health Inc. (NASDAQ:COSM) shares are trading slightly lower on Friday. The company revealed that its wholly owned ...

The tablets in the strength of 32mg are the generic version of Tracleer, developed by Actelion Pharmaceuticals US Inc, Natco ...

Cosmos Health (COSM) announced that its wholly owned subsidiary, Cana Laboratories, has entered into a new long-term ten-year contract ...